Patents by Inventor Douglas Beight

Douglas Beight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINOLINYL-PYRROLOPYRAZOLES
    Publication number: 20080027102
    Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
    Type: Application
    Filed: July 25, 2007
    Publication date: January 31, 2008
    Inventors: Douglas Beight, Jason Sawyer, Jonathan Yingling
  • Novel compounds as pharmaceutical agents
    Publication number: 20060058295
    Abstract: The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
    Type: Application
    Filed: November 24, 2003
    Publication date: March 16, 2006
    Applicant: Eli Lilly and Company
    Inventors: Douglas Beight, Timothy Burkholder, Todd Decollo, Alexander Godfrey, Charles Heap, Chi-Hsin King, Hong-Yu Li, William McMillen, Jason Sawyer, Yan Wang, Clive Diefenbacher, Thomas Engler, Sushant Malhotra, Sreenivasa Mundla
  • Quinolinyl-pyrrolopyrazoles
    Publication number: 20060040983
    Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
    Type: Application
    Filed: November 10, 2003
    Publication date: February 23, 2006
    Applicant: Eli Lilly and Company
    Inventors: Douglas Beight, Jason Sawyer, Jonathan Yingling
  • Aromatic amides
    Publication number: 20050282862
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: July 29, 2003
    Publication date: December 22, 2005
    Inventors: Douglas Beight, Trelia Craft, Carl Denny, Jeffry Franciskovich, Theodore Goodson, Steven Hall, David Herron, Sajan Joseph, Valentine Klimkowski, Jeffrey Kyle, John Masters, David Mendel, Guy Milot, Marta Pineiro-Nunez, Jason Sawyer, Robert Shuman, Gerald Smith, Anne Tebbe, Jennifer Tinsley, Leonard Weir, James Wikel, Michael Wiley, Ying Yee
  • Novel pyrazolopyridine derivatives as pharmaceutical agents
    Publication number: 20050222197
    Abstract: Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta.
    Type: Application
    Filed: September 16, 2003
    Publication date: October 6, 2005
    Inventors: Douglas Beight, Rosanne Bonjouklian, Junkai Liao, William McMillen, Brandon Parkhurst, Jason Sawyer, Jonathan Yingling, Jeremy York
  • Novel pyrrole derivatives as pharmaceutical agents
    Publication number: 20040106604
    Abstract: Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S.
    Type: Application
    Filed: November 6, 2003
    Publication date: June 3, 2004
    Inventors: Douglas Beight, Todd DeCollo, Alexander Glenn Godfrey, Theodore Goodson, Hong-Yu Li, William McMillen, Shawn Christopher Miller, Jason Sawyer, Edward C.R. Smith, Jonathan Michael Yingling